title: Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment.
authors.affiliation: Centre de Rhumatologie, Hôpital Pierre-Paul Riquet; laroche.m@chu-toulouse.fr.
authors.forename: Michel
authors.initials: M
authors.lastname: Laroche
authors.affiliation: Centre de Rhumatologie, Hôpital Pierre-Paul Riquet.
authors.forename: Marie
authors.initials: M
authors.lastname: Seniow
authors.affiliation: Institut Universitaire du Cancer Toulouse - Oncopole.
authors.forename: Henri
authors.initials: H
authors.lastname: Roché
authors.affiliation: Centre de Rhumatologie, Hôpital Pierre-Paul Riquet, Toulouse, France.
authors.forename: Adeline
authors.initials: A
authors.lastname: Ruyssen-Witrand
mesh_terms: D000368:Aged; D047072:Aromatase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D018771:Arthralgia / Q000139:chemically induced* / Q000453:epidemiology / Q000503:physiopathology; D001327:Autoimmune Diseases / Q000453:epidemiology / Q000503:physiopathology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D010147:Pain Measurement; D012189:Retrospective Studies; D018570:Risk Assessment; D028761:Withholding Treatment
chemical_list: D047072:Aromatase Inhibitors